Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: A randomized controlled trial

Journal of Pain and Symptom Management

Volumn 28, Issue 4, 2004, Pages 381-388

  Bruera, Eduardo ^a   Moyano, Jario Ricardo ^a   Sala, Raul ^a   Rico, Maria Antonieta ^a   Bosnjak, Snezanna ^a   Bertolino, Mariela ^a   Willey, Jie ^a   Strasser, Florian ^a   Palmer, J Lynn ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

advanced cancer; anorexia; Chronic nausea; clinical trial; dexamethasone; metoclopramide; palliative care

Indexed keywords

ANTIEMETIC AGENT; DEXAMETHASONE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO;

ADULT; ADVANCED CANCER; AGED; ANKLE EDEMA; APPETITE; ARTICLE; CANCER PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESSNESS; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WELLBEING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; APPETITIVE BEHAVIOR; CHRONIC DISEASE; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG RESISTANCE; EATING DISORDERS; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INTERNATIONALITY; MALE; METOCLOPRAMIDE; MIDDLE AGED; NAUSEA; NEOPLASMS; PALLIATIVE CARE; TERMINAL CARE; TREATMENT OUTCOME;

EID: 4744338321     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2004.01.009     Document Type: Article

References (21)

1. S. Donnelly, and D. Walsh The symptoms of advanced cancer Semin Oncol 22 1995 67 72
2. C. Ripamonti, and E. Bruera Gastrointestinal symptoms in advanced cancer patients C. Ripamonti E. Bruera Chronic nausea and vomiting 2002 Oxford University Press Oxford 169 192
3. E. Bruera, L. Seifert, and S. Watanabe Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen J Pain Symptom Manage 11 1996 147 153
4. E. Bruera, Z. Cata, and R. Hooper Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction J Pain Symptom Manage 2 1987 19 21
5. L. Manara, and A. Bianchetti The central and peripheral influence of opioids on gastrointestinal propulsion Ann Rev Pharmacol Toxicol 75 1985 249 273
6. C. Ripamonti, and C. Rodriguez Gastrointestinal motility disorders in patients with advanced cancer R. Portenoy E. Bruera Topics in palliative care, Volume 1 1997 Oxford University Press Oxford 61 94
7. K. Shivshanker, R.W. Bennett Jr., and T.P. Haynie Tumor-associated gastroparesis: correction with metoclopramide Am J Surg 145 1983 221 225
8. E.D. Bruera, T.J. MacEachern, and K.A. Spachynski Comparison of the efficacy, safety, and pharmacokinetics of controlled-release and immediaterelease metoclopramide for the management of chronic nausea in patients with advanced cancer Cancer 74 1994 3204 3211
9. E. Bruera, M. Belzile, and C. Neumann A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer J Pain Symptom Manage 19 2000 427 435
10. R.J. Gralla, D. Osoba, and M.G. Kris Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology J Clin Oncol 17 1999 2971 2994
11. J.P. Ioannidis, P.J. Hesketh, and J. Lau Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence J Clin Oncol 18 2000 3409 3422
12. P. Kirkbride, A. Bezjak, and J. Pater Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group Phase III study J Clin Oncol 18 2000 1960 1966
13. C.G. Moertel, A.J. Schutt, R.J. Reitemeier, and R.G. Hahn Corticosteroid therapy of preterminal gastrointestinal cancer Cancer 33 1974 1607 1609
14. J.C. Willox, J. Corr, and J. Shaw Prednisolone as an appetite stimulant in patients with cancer Br Med J 288 1984 27
15. E. Bruera, E. Roca, and L. Cedaro Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study Cancer Treat Rep 69 1985 751 754
16. A.B. Ettinger, and R.K. Portenoy The use of corticosteroids in the treatment of symptoms associated with cancer J Pain Symptom Manage 3 1988 99 103
17. T. Popiela, R. Lucchi, and F. Giongo Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group Eur J Cancer 25 12 1989 1823 1829
18. G.R. Della Cuna, A. Pellegrini, and M. Piazzi Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group Eur J Cancer Clin Oncol 25 1989 1817 1821
19. R. Twycross Corticosteroids in advanced cancer BMJ 305 1992 969 970
20. S. Mercadante, F. Fulfaro, and A. Casuccio The use of corticosteroids in home palliative care Support Care Cancer 9 2001 386 389
21. P. Rousseau The palliative use of high-dose corticosteroids in three terminally ill patients with pain Am J Hosp Palliat Care 18 2001 343 346